Date: 2014-11-11 06:38:10

Pharmacology

Pyrrolidines

Amides

Meropenem

Medicine

Swissmedic

Carbapenem

Pharmaceutical industry

Marketing authorization

Carbapenem antibiotics

Pharmaceuticals policy

Pharmaceutical sciences

11th November, 2014 Venus Receives Market Authorization for Meropenem from Switzerland (SWISSMEDIC) Venus Remedies Limited, a leading research based global pharmaceutical company, achieved yet another landmark by receivi

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 50,23 KB